-
Something wrong with this record ?
Distinct functional domains of Nbs1 modulate the timing and magnitude of ATM activation after low doses of ionizing radiation
Z Horejsi, J Falck, CJ Bakkenist, MB Kastan, J Lukas, J Bartek
Language English Country England, Great Britain
NLK
Free Medical Journals
from 1997 to 2004
ProQuest Central
from 2000-01-01 to 1 year ago
Open Access Digital Library
from 1997-01-01
Medline Complete (EBSCOhost)
from 1997-01-09 to 2015-11-26
Health & Medicine (ProQuest)
from 2000-01-01 to 1 year ago
Public Health Database (ProQuest)
from 2000-01-01 to 1 year ago
PubMed
15048089
Knihovny.cz E-resources
- MeSH
- Gene Amplification MeSH
- Ataxia Telangiectasia Mutated Proteins MeSH
- DNA-Binding Proteins MeSH
- Phosphorylation MeSH
- Phosphoserine metabolism MeSH
- Radiation, Ionizing MeSH
- Nuclear Proteins chemistry metabolism deficiency MeSH
- Kinetics MeSH
- Humans MeSH
- Tumor Suppressor Proteins MeSH
- Neoplasms genetics prevention & control MeSH
- DNA Damage genetics MeSH
- Protein Serine-Threonine Kinases * metabolism radiation effects MeSH
- Cell Cycle Proteins chemistry metabolism MeSH
- Ataxia Telangiectasia MeSH
- Binding Sites MeSH
- Cell Survival MeSH
- Check Tag
- Humans MeSH
The ATM kinase is a tumour suppressor and a key activator of genome integrity checkpoints in mammalian cells exposed to ionizing radiation (IR) and other insults that elicit DNA double-strand breaks (DSBs). In response to IR, autophosphorylation on serine 1981 causes dissociation of ATM dimers and initiates cellular ATM kinase activity. Here, we show that the kinetics and magnitude of ATM Ser1981 phosphorylation after exposure of human fibroblasts to low doses (2 Gy) of IR are altered in cells deficient in Nbs1, a substrate of ATM and a component of the MRN (Mre11-Rad50-Nbs1) complex involved in processing/repair of DSBs and ATM-dependent cell cycle checkpoints. Timely phosphorylation of both ATM Ser1981 and the ATM substrate Smc1 after IR were rescued via retrovirally mediated reconstitution of Nbs1-deficient cells by wild-type Nbs1 or mutants of Nbs1 defective in the FHA domain or nonphosphorylatable by ATM, but not by Nbs1 lacking the Mre11-interaction domain. Our data indicate that apart from its role downstream of ATM in the DNA damage checkpoint network, the MRN complex serves also as a modulator/amplifier of ATM activity. Although not absolutely required for ATM activation, the MRN nuclease complex may help reach the threshold activity of ATM necessary for optimal genome maintenance and prevention of cancer.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14079645
- 003
- CZ-PrNML
- 005
- 20141120141146.0
- 007
- ta
- 008
- 141120s2004 enk f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)15048089
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Hořejší, Zuzana $7 xx0122010 $u Danish Cancer Society, Institute of Cancer Biology, Strandboulevarden 49, Copenhagen DK-2100 Denmark.
- 245 10
- $a Distinct functional domains of Nbs1 modulate the timing and magnitude of ATM activation after low doses of ionizing radiation / $c Z Horejsi, J Falck, CJ Bakkenist, MB Kastan, J Lukas, J Bartek
- 520 9_
- $a The ATM kinase is a tumour suppressor and a key activator of genome integrity checkpoints in mammalian cells exposed to ionizing radiation (IR) and other insults that elicit DNA double-strand breaks (DSBs). In response to IR, autophosphorylation on serine 1981 causes dissociation of ATM dimers and initiates cellular ATM kinase activity. Here, we show that the kinetics and magnitude of ATM Ser1981 phosphorylation after exposure of human fibroblasts to low doses (2 Gy) of IR are altered in cells deficient in Nbs1, a substrate of ATM and a component of the MRN (Mre11-Rad50-Nbs1) complex involved in processing/repair of DSBs and ATM-dependent cell cycle checkpoints. Timely phosphorylation of both ATM Ser1981 and the ATM substrate Smc1 after IR were rescued via retrovirally mediated reconstitution of Nbs1-deficient cells by wild-type Nbs1 or mutants of Nbs1 defective in the FHA domain or nonphosphorylatable by ATM, but not by Nbs1 lacking the Mre11-interaction domain. Our data indicate that apart from its role downstream of ATM in the DNA damage checkpoint network, the MRN complex serves also as a modulator/amplifier of ATM activity. Although not absolutely required for ATM activation, the MRN nuclease complex may help reach the threshold activity of ATM necessary for optimal genome maintenance and prevention of cancer.
- 536 __
- $c Grant Number: CA 21765 (United States NCI NIH HHS)
- 536 __
- $c Grant Number: CA 71387 (United States NCI NIH HHS)
- 590 __
- $a bohemika - dle Pubmed
- 650 02
- $a teleangiektatická ataxie $7 D001260
- 650 02
- $a ATM protein $7 D064007
- 650 02
- $a vazebná místa $7 D001665
- 650 02
- $a proteiny buněčného cyklu $x chemie $x metabolismus $7 D018797
- 650 02
- $a viabilita buněk $7 D002470
- 650 02
- $a poškození DNA $x genetika $7 D004249
- 650 02
- $a DNA vazebné proteiny $7 D004268
- 650 02
- $a amplifikace genu $7 D005784
- 650 02
- $a lidé $7 D006801
- 650 02
- $a kinetika $7 D007700
- 650 02
- $a nádory $x genetika $x prevence a kontrola $7 D009369
- 650 02
- $a jaderné proteiny $x chemie $x metabolismus $x nedostatek $7 D009687
- 650 02
- $a fosforylace $7 D010766
- 650 02
- $a fosfoserin $x metabolismus $7 D010768
- 650 12
- $a protein-serin-threoninkinasy $x metabolismus $x účinky záření $7 D017346
- 650 02
- $a ionizující záření $7 D011839
- 650 02
- $a nádorové supresorové proteiny $7 D025521
- 700 1_
- $a Falck, J.
- 700 1_
- $a Bakkenist, C.J.
- 700 1_
- $a Kastan, M.B.
- 700 1_
- $a Lukáš, Jiří $7 xx0094305
- 700 1_
- $a Bártek, Jiří, $d 1953- $7 xx0046271
- 773 0_
- $t Oncogene $x 0950-9232 $g Roč. 23, č. 17 (2004), s. 3122-3127 $p Oncogene $w MED00003600
- 773 0_
- $p Oncogene $g 23(17):3122-7, 2004 Apr 15 $x 0950-9232
- 910 __
- $a ABA008 $y 4 $z 0
- 990 __
- $a 20141120141132 $b ABA008
- 991 __
- $a 20141120141227 $b ABA008
- 999 __
- $a ok $b bmc $g 1047990 $s 878664
- BAS __
- $a 3
- BMC __
- $a 2004 $b 23 $c 17 $d 3122-3127 $x MED00003600 $i 0950-9232 $m Oncogene $n Oncogene
- LZP __
- $a NLK 2014-1/lp